KCa3.1 ion channel targeting antibodies (Tetragenetics)

N/A

Report date: 2025/03/20 15:45:30

Base Information

Drug NameKCa3.1 ion channel targeting antibodies (Tetragenetics)
Drug Alias NameKCa3.1 ion channel targeting antibodies (AbCellera)
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody
Mechanisms of ActionIntermediate conductance calcium-activated potassium channel protein 4 modulators
TargetsIntermediate conductance calcium-activated potassium channel protein 4
Therapy Area/IndicationsAutoimmune Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesTetragenetics
China Registration ClassN/A

Develop Information

Active CompaniesTetrageneticsAbCellera Biologics Inc
Inactive CompaniesN/A
Active IndicationsAutoimmune Diseases
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A